US EditionFDA Begins Phasing Out Certain Animal Testing Practices: commissioner
- The U.S. Food and Drug Administration has initiated a program to reduce animal testing by using innovative human-relevant methods for drug development, particularly for monoclonal antibodies and pharmaceuticals.
- The FDA's new approach emphasizes New Approach Methodologies like AI-based toxicity models and organ-on-a-chip systems, which provide more accurate data compared to traditional animal testing.
- FDA Commissioner Martin A. Makary stated that this initiative represents a "paradigm shift in drug evaluation" and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use.
- The FDA plans to collaborate with other federal agencies to validate these methods, ultimately aiming to spare thousands of animals from testing each year as new techniques gain acceptance.
126 Articles
126 Articles
InsideNoVA.com
FDA Announces Plan to Phase Out Some Animal Testing
MONDAY, April 14, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs, favoring more effective, human-relevant methods.
Readers respond: Weighing the interests of animals
In defending OHSU’s experimentation on monkeys in its primate research center, Peter Barr-Gillespie and Skip Bohm make the same mistake many of my students did when I taught business and corporate ethics at Marylhurst University and the University of Portland: citing the benefits of a practice without addressing the harms, (“Opinion: Should OHSU’s primate research center be closed? Advocates for closure and OHSU researchers offer their views,” A…
FDA Announces Groundbreaking Shift: Replacing Animal Testing With Advanced Human-Relevant Methods For Drug Development
In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing with cutting-edge, human-relevant methodologies, particularly for monoclonal antibody therapies and other pharmaceuticals. This move aims to enhance drug safety, accelerate the evaluation process, lower research and […] FDA Announces Groundbreaking …
FDA Moves To Replace Animal Testing
The U.S. Food and Drug Administration (FDA) announced a plan to replace animal testing with “human-relevant methods.” “The U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. The new approach is...
FDA Moves To Replace Animal Testing * 100PercentFedUp.com * by Danielle
The FDA's bold initiative to replace animal testing with cutting-edge human-relevant methods promises to revolutionize drug development. Discover how AI and innovative lab models could transform public health and accelerate access to safer treatments.
Coverage Details
Bias Distribution
- 68% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
